As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting […]
As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime Read Post »
Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next
Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next
As Tony White Reads Resumes, Industry Buzzes Around Core Four It’s been two-and-a-half months since J. Craig walked away from
As Tony White Reads Resumes, Industry Buzzes Around Core Four Read Post »
President Presses Senate to Ban All Human Cloning Declaring that “life is a creation, not a commodity,” Bush pressed the
President Presses Senate to Ban All Human Cloning Read Post »
7 drug makers unveil elderly discounts Under pressure from consumers and lawmakers over drug prices, Abbott Laboratories and six other
Survival of fittest is new mode for biotechs Consolidation won’t slow, and that’s no bad thing, industry watchers say
Biotech booster shot Sector, regional economy stand to gain key ally as Harvard makes gesture to loosen its strained ties
Bad Genes, Good Drugs Wondering what happened to all that knowledge we got from mapping the human genome?
New `greenhouses’ to promote biotechnology businesses “With fanfare that extended beyond state boundaries into prime technological turf, Pennsylvania on Wednesday
New `greenhouses' to promote biotechnology businesses Read Post »
Get new actionable insights and updates from BiotechBlog
